Comerica Bank’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Comerica Bank’s Portfolio SGNT Stock Details SGNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-23,850	Closed	-$518K	–	2139
2016 Q2	$518K	Sell	23,850 -298	-1%	-$3.83K	﹤0.01%	1771
2016 Q1	$303K	Buy	24,148 +41	+0.2%	+$575	﹤0.01%	1910
2015 Q4	$322K	Buy	24,107 +128	+0.5%	+$2.02K	﹤0.01%	1845
2015 Q3	$368K	Sell	23,979 -21,581	-47%	-$466K	﹤0.01%	1813
2015 Q2	$1.11M	Buy	45,560 +23,151	+103%	+$555K	﹤0.01%	1727
2015 Q1	$521K	Sell	22,409 -21,539	-49%	-$570K	﹤0.01%	1745
2014 Q4	$1.1M	Buy	43,948 +21,664	+97%	+$636K	﹤0.01%	1723
2014 Q3	$693K	Buy	+22,284	New	+$604K	0.01%	1640

Comerica Bank's SGNT Position: Q3 2016 in Review

Comerica Bank sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 23,850 shares — an estimated $518K sold.

Comerica Bank first reported a position in SGNT in Q3 2014 and held it in 8 quarters. The position peaked at $1.11M in Q2 2015. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

Comerica Bank reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
Comerica Bank sold 23,850 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $518K.
Comerica Bank first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q3 2014 and held it in 8 quarters.
Comerica Bank's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $1.11M in Q2 2015.
0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Comerica Bank's 13F filing for Q3 2016, filed 10 Nov 2016.